• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

N6-甲基腺苷相关长链非编码RNA的预后特征建立及其在肝癌患者中的潜在功能

Establishment of Prognostic Signatures of N6-Methyladenosine-Related lncRNAs and Their Potential Functions in Hepatocellular Carcinoma Patients.

作者信息

Wu Xianbin, Deng Zhejun, Liao Xiaomin, Ruan Xianxian, Qu Nanfang, Pang Lixing, Shi Xiaoyan, Qin Shanyu, Jiang Haixing

机构信息

Department of Gastroenterology, The First Afliated Hospital of Guangxi Medical University, Nanning, China.

Department of Gastroenterology, The Third Affifiliated Hospital of Guangxi Medical University, Nanning, China.

出版信息

Front Oncol. 2022 Jun 6;12:865917. doi: 10.3389/fonc.2022.865917. eCollection 2022.

DOI:10.3389/fonc.2022.865917
PMID:35734590
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9207396/
Abstract

N6-methyladenosine (m6a)-related mRNAs and lncRNAs have been explored for their functions in several cancers. The present study aimed to identify potential signatures of m6a-related lncRNAs in hepatocellular carcinoma (HCC). We downloaded the expression and clinical data from The Cancer Genome Atlas (TCGA) database. The interacted mRNAs and lncRNAs, prognosis-related lncRNAs, potential metabolic pathways of lncRNAs, immune infiltration of various cells, and CD274 (PD-L1) -related lncRNAs were analyzed. Then, experiments explored the role of AC012073.1 (LOC105377626) in HCC cell lines. We found that candidate 14 lncRNA signatures play functions in HCC maybe by affecting immune infiltration, cell cycle, Notch signaling pathway, etc. LncRNA AC012073.1 (LOC105377626) functions as oncogenic roles in affecting HCC prognosis.

摘要

N6-甲基腺苷（m6A）相关的信使核糖核酸（mRNA）和长链非编码核糖核酸（lncRNA）在多种癌症中的功能已得到研究。本研究旨在确定肝细胞癌（HCC）中m6A相关lncRNA的潜在特征。我们从癌症基因组图谱（TCGA）数据库下载了表达和临床数据。分析了相互作用的mRNA和lncRNA、与预后相关的lncRNA、lncRNA的潜在代谢途径、各种细胞的免疫浸润以及与CD274（程序性死亡受体配体1，PD-L1）相关的lncRNA。然后，实验探讨了AC012073.1（LOC105377626）在肝癌细胞系中的作用。我们发现，候选的14个lncRNA特征可能通过影响免疫浸润、细胞周期、Notch信号通路等在肝癌中发挥作用。lncRNA AC012073.1（LOC105377626）在影响肝癌预后方面发挥致癌作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b80c/9207396/160114ba0f4d/fonc-12-865917-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b80c/9207396/32b3f451f4ac/fonc-12-865917-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b80c/9207396/e5c76c7362f9/fonc-12-865917-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b80c/9207396/0cfc6508ded7/fonc-12-865917-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b80c/9207396/fc7a12bbf0c4/fonc-12-865917-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b80c/9207396/5e093d93b90e/fonc-12-865917-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b80c/9207396/baaf5dbdc5a3/fonc-12-865917-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b80c/9207396/430085d8d1bf/fonc-12-865917-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b80c/9207396/a61d19677148/fonc-12-865917-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b80c/9207396/139a7bf4593f/fonc-12-865917-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b80c/9207396/160114ba0f4d/fonc-12-865917-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b80c/9207396/32b3f451f4ac/fonc-12-865917-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b80c/9207396/e5c76c7362f9/fonc-12-865917-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b80c/9207396/0cfc6508ded7/fonc-12-865917-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b80c/9207396/fc7a12bbf0c4/fonc-12-865917-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b80c/9207396/5e093d93b90e/fonc-12-865917-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b80c/9207396/baaf5dbdc5a3/fonc-12-865917-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b80c/9207396/430085d8d1bf/fonc-12-865917-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b80c/9207396/a61d19677148/fonc-12-865917-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b80c/9207396/139a7bf4593f/fonc-12-865917-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b80c/9207396/160114ba0f4d/fonc-12-865917-g010.jpg

相似文献

1
Establishment of Prognostic Signatures of N6-Methyladenosine-Related lncRNAs and Their Potential Functions in Hepatocellular Carcinoma Patients.N6-甲基腺苷相关长链非编码RNA的预后特征建立及其在肝癌患者中的潜在功能
Front Oncol. 2022 Jun 6;12:865917. doi: 10.3389/fonc.2022.865917. eCollection 2022.
2
Identification of m6A methyltransferase-related lncRNA signature for predicting immunotherapy and prognosis in patients with hepatocellular carcinoma.鉴定 m6A 甲基转移酶相关的长链非编码 RNA 特征，以预测肝细胞癌患者的免疫治疗和预后。
Biosci Rep. 2021 Jun 25;41(6). doi: 10.1042/BSR20210760.
3
Comprehensive Analysis of N6-Methyladenosine-Related IncRNAs Prognostic Signature and the Associated Immune Infiltrates in Kidney Renal Clear Cell Carcinoma.N6-甲基腺苷相关长非编码 RNA 预后特征综合分析及其与肾透明细胞癌免疫浸润的相关性。
Crit Rev Eukaryot Gene Expr. 2022;32(1):79-98. doi: 10.1615/CritRevEukaryotGeneExpr.2021039325.
4
Comprehensive analysis of N6-methyladenosine -related long non-coding RNAs and immune cell infiltration in hepatocellular carcinoma.全面分析肝细胞癌中 N6-甲基腺苷相关的长非编码 RNA 与免疫细胞浸润。
Bioengineered. 2021 Dec;12(1):1708-1724. doi: 10.1080/21655979.2021.1923381.
5
LINC00665 regulates hepatocellular carcinoma by modulating mRNA via the m6A enzyme.LINC00665通过m6A酶调节mRNA来调控肝细胞癌。
Open Life Sci. 2022 Feb 11;17(1):71-80. doi: 10.1515/biol-2022-0003. eCollection 2022.
6
Identification of a N6-Methyladenosine (m6A)-Related lncRNA Signature for Predicting the Prognosis and Immune Landscape of Lung Squamous Cell Carcinoma.用于预测肺鳞状细胞癌预后和免疫格局的N6-甲基腺苷（m6A）相关长链非编码RNA特征的鉴定
Front Oncol. 2021 Nov 18;11:763027. doi: 10.3389/fonc.2021.763027. eCollection 2021.
7
Integrated analysis on the N6-methyladenosine-related long noncoding RNAs prognostic signature, immune checkpoints, and immune cell infiltration in clear cell renal cell carcinoma.N6-甲基腺苷相关长非编码 RNA 预后signature、免疫检查点和免疫细胞浸润的综合分析在透明细胞肾细胞癌中的研究。
Immun Inflamm Dis. 2021 Dec;9(4):1596-1612. doi: 10.1002/iid3.513. Epub 2021 Aug 25.
8
Comprehensive analysis of N6-methyladenosine-related lncRNAs reveals distinct hepatocellular carcinoma subtypes with immunotherapeutic implications.对N6-甲基腺嘌呤相关长链非编码RNA的综合分析揭示了具有免疫治疗意义的不同肝细胞癌亚型。
Am J Transl Res. 2022 Sep 15;14(9):6504-6520. eCollection 2022.
9
Use of 6 m6A-relevant lncRNA genes as prognostic markers of primary liver hepatocellular carcinoma based on TCGA database.基于TCGA数据库，使用6个与m6A相关的lncRNA基因作为原发性肝细胞癌的预后标志物。
Transl Cancer Res. 2021 Dec;10(12):5337-5351. doi: 10.21037/tcr-21-2440.
10
Expression and prognostic signatures of m6A-related lncRNAs in hepatocellular carcinoma.m6A 相关 lncRNAs 在肝细胞癌中的表达和预后特征。
J Cancer Res Clin Oncol. 2023 Jul;149(8):4429-4441. doi: 10.1007/s00432-022-04338-x. Epub 2022 Sep 19.

引用本文的文献

1
Inhibiting the expression of spindle appendix cooled coil protein 1 can suppress tumor cell growth and metastasis and is associated with cancer immune cells in esophageal squamous cell carcinoma.抑制纺锤体附件冷却线圈蛋白 1 的表达可以抑制肿瘤细胞的生长和转移，并与食管鳞状细胞癌中的癌症免疫细胞有关。
PLoS One. 2024 Aug 28;19(8):e0302312. doi: 10.1371/journal.pone.0302312. eCollection 2024.
2
METTL3 and METTL14-mediated N-methyladenosine modification of SREBF2-AS1 facilitates hepatocellular carcinoma progression and sorafenib resistance through DNA demethylation of SREBF2.METTL3 和 METTL14 介导的 SREBF2-AS1 的 N6-甲基腺苷修饰通过 SREBF2 的 DNA 去甲基化促进肝细胞癌进展和索拉非尼耐药。
Sci Rep. 2024 Mar 14;14(1):6155. doi: 10.1038/s41598-024-55932-7.
3

本文引用的文献

1
LncRNA AC099850.3 promotes hepatocellular carcinoma proliferation and invasion through PRR11/PI3K/AKT axis and is associated with patients prognosis.长链非编码RNA AC099850.3通过PRR11/PI3K/AKT轴促进肝细胞癌的增殖和侵袭，并与患者预后相关。
J Cancer. 2022 Jan 4;13(3):1048-1060. doi: 10.7150/jca.66092. eCollection 2022.
2
SOX9/MKLN1-AS Axis Induces Hepatocellular Carcinoma Proliferation and Epithelial-Mesenchymal Transition.SOX9/MKLN1-AS 轴诱导肝细胞癌增殖和上皮-间充质转化。
Biochem Genet. 2022 Dec;60(6):1914-1933. doi: 10.1007/s10528-022-10196-6. Epub 2022 Feb 9.
3
Novel lncRNA Panel as for Prognosis in Esophageal Squamous Cell Carcinoma Based on ceRNA Network Mechanism.
mA modification of AC026356.1 facilitates hepatocellular carcinoma progression by regulating the IGF2BP1-IL11 axis.mA 对 AC026356.1 的修饰通过调节 IGF2BP1-IL11 轴促进肝癌进展。
Sci Rep. 2023 Nov 5;13(1):19124. doi: 10.1038/s41598-023-45449-w.
4
N-Methyladenosine-Modified ATP8B1-AS1 Exerts Oncogenic Roles in Hepatocellular Carcinoma via Epigenetically Activating MYC.N-甲基腺苷修饰的ATP8B1-AS1通过表观遗传激活MYC在肝细胞癌中发挥致癌作用。
J Hepatocell Carcinoma. 2023 Sep 6;10:1479-1495. doi: 10.2147/JHC.S415318. eCollection 2023.
5
Identification of a CD4+ conventional T cells-related lncRNAs signature associated with hepatocellular carcinoma prognosis, therapy, and tumor microenvironment.鉴定与肝细胞癌预后、治疗和肿瘤微环境相关的 CD4+ 常规 T 细胞相关 lncRNAs 特征。
Front Immunol. 2023 Jan 9;13:1111246. doi: 10.3389/fimmu.2022.1111246. eCollection 2022.
6
METTL3-induced DLGAP1-AS2 promotes non-small cell lung cancer tumorigenesis through mA/c-Myc-dependent aerobic glycolysis.METTL3 诱导的 DLGAP1-AS2 通过 mA/c-Myc 依赖性有氧糖酵解促进非小细胞肺癌肿瘤发生。
Cell Cycle. 2022 Dec;21(24):2602-2614. doi: 10.1080/15384101.2022.2105885. Epub 2022 Aug 16.
基于 ceRNA 网络机制的新型长链非编码 RNA panel 用于预测食管鳞癌预后。
Comput Math Methods Med. 2021 Sep 24;2021:8020879. doi: 10.1155/2021/8020879. eCollection 2021.
4
Integrative Analysis Reveals Potentially Functional N6-Methylandenosine-Related Long Noncoding RNAs in Colon Adenocarcinoma.综合分析揭示了结肠癌中潜在具有功能的N6-甲基腺苷相关长链非编码RNA
Front Genet. 2021 Sep 17;12:739344. doi: 10.3389/fgene.2021.739344. eCollection 2021.
5
LncRNA LBX2-AS1 promotes colorectal cancer progression and 5-fluorouracil resistance.长链非编码RNA LBX2-AS1促进结直肠癌进展及5-氟尿嘧啶耐药。
Cancer Cell Int. 2021 Sep 17;21(1):501. doi: 10.1186/s12935-021-02209-y.
6
N6-methylandenosine-related lncRNAs play an important role in the prognosis and immune microenvironment of pancreatic ductal adenocarcinoma.N6-甲基腺苷相关长链非编码 RNA 在胰腺导管腺癌的预后和免疫微环境中发挥重要作用。
Sci Rep. 2021 Sep 8;11(1):17844. doi: 10.1038/s41598-021-97362-9.
7
RNA mA Modification Plays a Key Role in Maintaining Stem Cell Function in Normal and Malignant Hematopoiesis.RNA mA修饰在正常和恶性造血过程中维持干细胞功能方面发挥关键作用。
Front Cell Dev Biol. 2021 Aug 13;9:710964. doi: 10.3389/fcell.2021.710964. eCollection 2021.
8
Integrated analysis on the N6-methyladenosine-related long noncoding RNAs prognostic signature, immune checkpoints, and immune cell infiltration in clear cell renal cell carcinoma.N6-甲基腺苷相关长非编码 RNA 预后signature、免疫检查点和免疫细胞浸润的综合分析在透明细胞肾细胞癌中的研究。
Immun Inflamm Dis. 2021 Dec;9(4):1596-1612. doi: 10.1002/iid3.513. Epub 2021 Aug 25.
9
A Risk Signature Consisting of Eight mA Methylation Regulators Predicts the Prognosis of Glioma.一个由 8 个 mA 甲基化调节剂组成的风险特征可预测胶质瘤的预后。
Cell Mol Neurobiol. 2022 Nov;42(8):2733-2743. doi: 10.1007/s10571-021-01135-x. Epub 2021 Aug 25.
10
Expression Status and Prognostic Value of mA RNA Methylation Regulators in Lung Adenocarcinoma.肺腺癌中 mA RNA 甲基化调节因子的表达状态及预后价值
Life (Basel). 2021 Jun 26;11(7):619. doi: 10.3390/life11070619.